Next Article in Journal
Managing Malignant Pleural Mesothelioma in the Age of Personalized Medicine: Where Are We and What Is Still Missing?
Previous Article in Journal
Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster
Previous Article in Special Issue
UCHL5 Promotes Proliferation and Migration of Bladder Cancer Cells by Activating c-Myc via AKT/mTOR Signaling
 
 
Review

Article Versions Notes

Cancers 2022, 14(22), 5539; https://doi.org/10.3390/cancers14225539
Action Date Notes Link
article pdf uploaded. 10 November 2022 17:35 CET Version of Record https://www.mdpi.com/2072-6694/14/22/5539/pdf-vor
article xml file uploaded 17 November 2022 03:43 CET Original file -
article xml uploaded. 17 November 2022 03:43 CET Update https://www.mdpi.com/2072-6694/14/22/5539/xml
article pdf uploaded. 17 November 2022 03:43 CET Updated version of record https://www.mdpi.com/2072-6694/14/22/5539/pdf
article html file updated 17 November 2022 03:45 CET Original file -
article html file updated 17 November 2022 03:45 CET Update -
article html file updated 28 February 2023 22:29 CET Update -
article html file updated 2 March 2023 22:31 CET Update https://www.mdpi.com/2072-6694/14/22/5539/html
Back to TopTop